Diagonal Therapeutics
Advancing clustering antibodies to correct disease at the root
Watertown, United States · Founded 2022
- Headquarters
- Watertown, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Website
- diagonaltx.com
- Last Round
- Series BJan 2026
- Rounds
- 2
About
Diagonal Therapeutics pioneers a new class of clustering antibody medicines designed to correct the root causes of severe genetic and immune-mediated diseases. Founded in 2022, the company's lead program DIAG723 targets HHT by restoring ALK1 signaling and is advancing toward clinical trials in 2026.
Summary
Diagonal Therapeutics is a Biotech company based in Watertown, United States, founded in 2022. Its most recent funding was a Series B round in Jan 2026. Investors include BVF Partners, Atlas Venture and Sanofi Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
BVF Partners
2 rounds
Atlas Venture
2 rounds
Sanofi Ventures
1 round
Janus Henderson Investors
1 round
Lightspeed VP
2 rounds
RA Capital Management
2 rounds
Frazier Life Sciences
2 rounds
Viking Global
2 rounds
Velosity Capital
2 rounds
Checkpoint Capital
2 rounds
Deep Track Capital
1 round
EcoR1 Capital
1 round
Logos Capital
1 round
Balyasny Asset Management
1 round
Woodline Partners
1 round
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.